PRTCL / Peptides
Library · Updated September 2026
Peptides, and how to track them.
What each peptide is, its US regulatory status as of September 2026, and what to log: from FDA-approved GLP-1 medicines such as Semaglutide and Tirzepatide to research peptides that are not approved.
GLP-1 medicines
Research peptides
BPC-157
Body Protection Compound 157
Not FDA-approvedTB-500
Thymosin Beta-4 fragment
Not FDA-approvedGHK-Cu
Copper peptide
Limited approvalMOTS-c
Mitochondrial ORF of the 12S rRNA type-c
Not FDA-approvedEpitalon
Epithalon, AEDG peptide
Not FDA-approvedSemax
ACTH (4-10) analog
Not FDA-approvedSelank
Tuftsin analog
Not FDA-approvedAOD-9604
hGH fragment 176-191 (modified)
Not FDA-approvedKPV
Lys-Pro-Val tripeptide
Not FDA-approvedThymosin Alpha 1
TA-1, Thymalfasin
Not FDA-approvedGrowth hormone secretagogues
CJC-1295
Modified GRF (1-29), with or without DAC
Not FDA-approvedIpamorelin
Ipamorelin acetate
Not FDA-approvedSermorelin
GRF (1-29)
Limited approvalTesamorelin
TESA, Egrifta
FDA-approvedOther peptides
Related compounds
Metabolic research compounds
Comparisons
Semaglutide vs Tirzepatide
Semaglutide vs Tirzepatide: how they work, brand names, FDA-approved uses and what the SUR…
Tirzepatide vs Retatrutide
Tirzepatide vs Retatrutide: dual vs triple agonist, FDA status, Phase 3 weight-loss result…
BPC-157 vs TB-500
BPC-157 vs TB-500: where each comes from, what the research covers, their FDA status after…
Be informed. Every claim on this page links to its source. Read the studies, do your own research, and talk to a licensed healthcare provider before you start, stop or change anything. PRTCL tracks your protocol; it does not give medical advice.
Start with one protocol
Track it in one system.
PRTCL runs peptides, supplements, nutrition and training together, with reminders at the times you set, reconstitution math, site rotation and inventory that counts itself down. Launching on Android and iPhone the same day. Join the waitlist and enter the draw for one of 57 lifetime Premium subscriptions.